- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Trump and Rogan Meet in Oval Office to Discuss Psychedelics
The president signed an executive order to expedite research into using psychedelics to treat mental illness.
Apr. 18, 2026 at 4:48pm
Got story updates? Submit your updates here. ›
The unexpected meeting between President Trump and podcast host Joe Rogan highlights the growing bipartisan interest in exploring the potential medical uses of psychedelics.Washington TodayPresident Donald Trump and podcast host Joe Rogan met in the Oval Office on Saturday, where Trump signed an executive order directing the FDA to boost research into the use of psychedelics such as LSD, MDMA, and ibogaine to treat mental illness. Rogan, who had previously sent Trump information on the benefits of ibogaine in combating opioid addiction, stood alongside Health Secretary Robert F. Kennedy Jr. and Dr. Mehmet Oz as the president signed the order.
Why it matters
The meeting between Trump and Rogan, despite their political differences, highlights the growing bipartisan interest in exploring the potential medical uses of psychedelics, which are currently classified as Schedule I drugs with no accepted medical use. This executive order could pave the way for further research and potential rescheduling of these substances.
The details
During the meeting, Rogan expressed particular interest in ibogaine, a compound found in the roots of the African shrub iboga, which has shown promise in treating opioid and cocaine addiction. Trump jokingly asked if he could have some of the substance, saying he doesn't 'have time to be depressed' and that 'if you stay busy enough, maybe that works too'.
- The meeting took place on Saturday, April 18, 2026 in the Oval Office.
- Trump signed the executive order during the meeting.
The players
Donald Trump
The 79-year-old President of the United States.
Joe Rogan
A 58-year-old podcast host who has publicly broken from Trump on various issues in the past.
Robert F. Kennedy Jr.
The current Health Secretary under the Trump administration.
Dr. Mehmet Oz
The administrator of the Centers for Medicare and Medicaid Services.
What they’re saying
“We all respect Joe and he's a little bit more liberal than I am.”
— Donald Trump, President of the United States
“I wanna tell everybody how this happened. I sent President Trump some information. We have a gigantic opiate problem in this country, obviously.”
— Joe Rogan, Podcast Host
“This thing, everybody thought it was incredible. And I told Bobby, I said, 'Bobby, let's just do it and get Oz involved and it's gonna get done so quickly' and you guys did a great job.”
— Donald Trump, President of the United States
What’s next
The FDA will now work to expedite research into the use of psychedelics to treat mental illness, as directed by the executive order signed by President Trump.
The takeaway
The meeting between Trump and Rogan, despite their political differences, demonstrates the growing bipartisan interest in exploring the potential medical benefits of psychedelics, which could lead to a rescheduling of these substances and increased access for research and treatment.
Washington top stories
Washington events
Apr. 18, 2026
DC Defenders vs. St. Louis BattlehawksApr. 18, 2026
Glow Block Party: Chris LakeApr. 18, 2026
Nimesh Patel: With All Due Disrespect Tour




